Patents Assigned to Validogen GmbH
  • Publication number: 20230257792
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Application
    Filed: September 12, 2022
    Publication date: August 17, 2023
    Applicants: BOEHRINGER INGELHEIM RCV GMBH & CO KG, LONZA LTD., VALIDOGEN GMBH
    Inventors: Karlheinz Grillitsch, Guenther Daum, Andreas Grutsch
  • Patent number: 11479798
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: October 25, 2022
    Assignees: BOEHRINGER INGELHEIM RCV GMBH & CO KG, SANDOZ AG, VALIDOGEN GMBH, BIOMIN HOLDING GMBH, LONZA LTD.
    Inventors: Karlheinz Grillitsch, Guenther Daum, Andreas Grutsch
  • Patent number: 10590427
    Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: March 17, 2020
    Assignees: Boehringer Ingelheim RCV GmbH & Co KG, Lonza Ltd., Validogen GmbH
    Inventors: Brigitte Gasser, Diethard Mattanovich, Markus Buchetics